Efficacy of hospital cleaning agents and germicides against epidemic Clostridium difficile strains

Infection Control and Hospital Epidemiology

Volumn 28, Issue 8, 2007, Pages 920-925

  Fawley, Warren N ^a   Underwood, Sarah ^b   Freeman, Jane ^a   Baines, Simon D ^b   Saxton, Katie ^b   Stephenson, Keith ^b   Owens Jr , Robert C ^c   Wilcox, Mark H ^a,b  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c MAINE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERICIDE; CHEMICAL AGENT; CHLORINE; DETERGENT; DISINFECTANT AGENT; HYDROGEN PEROXIDE; HYPOCHLORITE; PHOSPHATE; SURFACTANT; TROCLOSENE;

ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL SURVIVAL; CELL POPULATION; CLINICAL EFFECTIVENESS; CLOSTRIDIUM DIFFICILE; CONCENTRATION RESPONSE; EMULSION; FECES; GROWTH INHIBITION; HOSPITAL; IN VITRO STUDY; INFECTION CONTROL; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; SPOROGENESIS;

ANTI-BACTERIAL AGENTS; CLOSTRIDIUM DIFFICILE; CROSS INFECTION; DETERGENTS; HUMANS; HYDROGEN PEROXIDE; MICROBIAL SENSITIVITY TESTS; SODIUM HYPOCHLORITE; SPORES, BACTERIAL;

EID: 34347368903     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/519201     Document Type: Article

References (33)

1. Communicable Disease Surveillance Centre. Voluntary reporting of Clostridium difficile, England, Wales, and Northern Ireland: 2004. Commun Dis Rep CDR Wkly 2005; 15:1-3. Available at: http://www.hpa.org. uk/CDR/. Accessed June 12, 2007.
2. Archibald LK, Banerjee SN, Jarvis WR. Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001. J Infect Dis 2004; 189:1585-1589.
3. Wilcox MH, Cunniffe JG, Trundle C, Redpath C. Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect 1996; 34:23-30.
4. Kyne L, Hamel MB, Polavaram R, Kelly CP. Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile. Clin Infect Dis 2002; 34:346-353.
5. Cartmill TDI, Panigrahi H, Worsley MA, McCann DC, Nice CN, Keith E. Management and control of a large outbreak of diarrhoea due to Clostridium difficile. J Hosp Infect 1994; 27:1-15.
6. Samore MH, Venkataraman L, DeGirolami PC, Arbeit RD, Karchmer AW. Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea. Am J Med 1996; 100:32-40.
7. Wilcox MH, Fawley WN, Wigglesworth N, Parnell P, Verity P, Freeman J. Comparison of effect of detergent versus hypochlorite cleaning on environmental contamination and incidence of Clostridium difficile infection. J Hosp Infect 2003; 54:109-114.
8. Russell AD. Bacterial resistance to disinfectants: present knowledge and future problems. J Hosp Infect 1999; 43(suppl):S57-68.
9. Department of Health and Public Health Laboratory Service foint Working Group. Clostridium difficile Infection: Prevention and Management. Heywood, UK: BAPS Health Publications Unit; 1994. Available at: http://www.hpa.org.uk/infections/topics_az/clostridium_difficile. Accessed June 12, 2007.
10. Stubbs SL, Brazier JS, O'Neill GL, Duerden BI. PCR targeted to the 16S-23S rRNA gene intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 1999; 37:461-463.
11. Wullt M, Burman LG, Laurell MH, Akerlund T. Comparison of AP-PCR typing and PCR-ribotyping for estimation of nosocomial transmission of Clostridium difficile. J Hosp Infect 2003; 55:124-130.
12. Johnson S, Samore MH, Farrow KA, et al. Epidemics of diarrhea caused by a clindamycin-resistant strain of Clostridium difficile in four hospitals. N Engl J Med 1999; 341:1645-1651.
13. Kato H, Kato N, Watanabe K, et al. Analysis of Clostridium difficile isolates from nosocomial outbreaks at three hospitals in diverse areas of Japan. J Clin Microbiol 2001; 39:1391-1395.
14. Brazier, JS. The epidemiology and typing of Clostridium difficile. J Antimicrob Chemother 1998; 41 (suppl C):47-57.
15. van Dijck P, Avesani V, Delmee M. Genotyping of outbreak-related and sporadic isolates of Clostridium difficile belonging to serogroup C. J Clin Microbiol 1996; 34:3049-3055.
16. Barbut F, Corthier G, Charpak Y, et al. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients: a French multicenter study. Arch Intern Med 1996; 156:1449-1454.
17. Communicable Disease Surveillance Centre. Outbreak of Clostridium difficile infection in a hospital in South East England. Commun Dis Rep CDR Wkly 2005; 15:1-2. Available at http://www.hpa.org.uk/cdr/archives/ archive05/News/news2405.htm. Accessed June 12, 2007.
18. McDonald LC, Killgore GE, Thompson A, et al. An epidemic, toxin gene-variant strain of Clostridium difficile. N Engl J Med 2005; 353:2433-2441.
19. Pépin J, Valiquette L, Alary ME, et al. Clostridium difficile-associated diarrhoea in a region of Quebec from 1991 to 2003: a changing pattern of diseases severity. CMAJ 2004; 171:466-472.
20. Pépin J, Alary ME, Valiquette L, et al. Increasing risk of relapse after treatment of Clostridium difficile colitis in Quebec, Canada. Clin Infect Dis 2005; 40:1591-1597.
21. van Steenbergen J, Debast S, van Kregten, R, van den Berg J, Notermans D. Kuijper E. Isolation of Clostridium difficile ribotype 027, toxinotype III in the Netherlands after increase in C. difficile-associated diarrhoea. Euro Surveill 2005; 10:E050714.1.
22. Wilcox MH, Fawley WN. Hospital disinfectants and spore formation by Clostridium difficile. Lancet 2000; 356:1324.
23. Baines SD, Freeman J, Wilcox MH. Effects of piperacillin/tazobactam on Clostridium difficile growth and toxin production in a human gut model. J Antimicrob Chemother 2005; 55:974-982.
24. Hota B. Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection? Clin Infect Dis 2004; 39:1182-1189.
25. Wilcox MH, Fawley WN, Parnell P. Value of lysozyme agar incorporation and alkaline thioglycollate exposure for the environmental recovery of Clostridium difficile. J Hosp Infect 2000; 44:65-69.
26. Rutala WA, Gergen MF, Weber DJ. Inactivation of Clostridium difficile spores by disinfectants. Infect Control Hosp Epidemiol 1993; 14:36-39.
27. Perez J, Springthorpe VS, Sattar SA. Activity of selected oxidizing microbicides against the spores of Clostridium difficile: relevance to environmental control. Am J Infect Control 2005; 33:320-325.
28. Block C. The effect of Perasafe and sodium dichloroisocyanurate (NaDCC) against spores of Clostridium difficile and Bacillus atrophaeus on stainless steel and polyvinyl chloride surfaces. J Hosp Infect 2004; 57:144-148.
29. Otter JA, French GL, Adams NM, Watling D, Parks MJ. Hydrogen peroxide vapour decontamination in an overcrowded tertiary care referral centre: some practical answers. J Hosp Infect 2006; 62: 384-385.
30. Mayfield JL, Leet T, Miller J, Mundy LM. Environmental control to reduce transmission of Clostridium difficile. Clin Infect Dis 2000; 331:995-1000.
31. Kaatz GW, Gitlin SD, Schaberg DR, Wilson KH, Kauffman CA, Seo SM. Acquisition of Clostridium difficile from the hospital environment. Am J Epidemiol 1988; 127: 1289-1293.
32. Fawley WN, Wilcox MH. Molecular epidemiology of endemic Clostridium difficile infection. Epidemiol Infect 2001; 126:343-350.
33. Bloomfield SF, Uso EE. The antibacterial properties of sodium hypochlorite and sodium dichloroisocyanurate as hospital disinfectants. J Hosp Infect 1985; 6:20-30.